Last deal

$18M

Amount

Series E

Stage

27.11.2012

Date

5

all rounds

$58.9M

Total amount

General

About Company
TriReme Medical develops stent technologies for coronary artery bifurcations.

Industry

Sector :

Subsector :

Keywords :

Also Known As

TMI

founded date

01.01.2005

Number of employees

Company Type

For Profit

Last funding type

Series E

IPO status

Private

Description

TriReme Medical is a California-based medical device company that creates advanced therapeutic technology systems for treating complex vascular disease. Its focus is on developing next-generation percutaneous devices for treating coronary and peripheral vascular disease. The company's balloon and stent therapies are designed to meet the unmet clinical needs in complex coronary and peripheral artery disease markets, providing physicians with new and differentiated devices to improve outcomes in complex peripheral and coronary interventions.
Contacts